Background. Atherosclerotic stenoses that have exaggerated vasomotor responses are especially prone to restenosis after coronary angioplasty. Experimental studies show that vasomotor responses in normal vessels are altered by acute mechanical injury, an alteration that in part reflects changes in the functional characteristics of endothelium that has regenerated after injury.
Methods and Results. We examined, by quantitative coronary arteriography, the response of dilated and control coronary segments to intracoronary infusions of graded doses of serotonin, an endotheliumdependent vasoactive agent, and to intracoronary injection of isosorbide dinitrate, an endotheliumindependent smooth muscle dilator in 15 patients who had undergone a single percutaneous transluminal coronary angioplasty procedure and who had no clinical features of variant angina. Dose-dependent constriction to serotonin occurred at all measured sites. The mean±SEM diameter reductions, expressed as percent reduction in baseline diameter that was observed at proximal (18.1±2.9, 18.8±2.2) and distal (30.9±4.4, 35.4±5.3) control sites in the dilated and nondilated vessels, respectively, at the highest dose, were similar. The degree of constriction in distal segments was significantly (P<.01) greater than that in proximal segments. Total or subtotal occlusion occurred at the angioplasty site in 4 patients at the highest infused dose (10-`mol/L). The mean percent reduction in baseline diameter at previously dilated sites (53.8±5.9) at this dose was significantly (P<.05) greater than that observed at the adjacent proximal control sites and similar to that observed at distal control sites. All segments dilated significantly after intracoronary injection of isosorbide dinitrate.
Conclusions. In dilated and nondilated vessels, serotonin caused significantly more marked constriction in distal than in proximal vessel segments. In dilated vessels, the vessel segments that had been subjected to angioplasty had a constrictor response to serotonin that was more marked than at adjacent proximal control sites and equivalent to that in the distal vessel segments. This enhanced constrictor response could be related to changes in endothelial cell function after regeneration or to hyperreactivity of 
Drugs
Serotonin creatinine sulfate was prepared by the Hammersmith Hospital Pharmacy (London, UK) and stored at -200C in ampoules containing 5 mL of 10-2 molar solution until just before use. The stock solution was diluted with normal (0.9%) saline to achieve final infused concentrations of 10-6 through 10-4 mol/IL. Study Protocol Femoral arterial pressure, heart rate, and two ECG leads (V2 and Vs) were recorded continuously throughout the study. After diagnostic arteriography, an optimal view was chosen to visualize the artery under study. A previous study has shown that random fluctuations or systematic changes caused by repeated infusions of saline have no significant effect on coronary diameter. 7 We have shown that repeated injections, performed at 2-minute intervals, of the contrast medium used in this study have no significant effect on coronary diameter. 8 The patients therefore received an infusion of vehicle solution (0.9% saline) followed by 2-minute infusions of serotonin creatinine sulfate (10-6 through 10-4 mol/L).
All infusions were administered through 8F Judkins catheters at room temperature at a rate of 1 mL/min with a syringe pump (Perfusor, Braun-Melsungen). An intracoronary bolus dose (2 mg) of isosorbide dinitrate diluted in normal (0.9%) saline was injected into the 
Quantitative Coronary Angiography
The coronary arteriograms were analyzed with the CAESAR (Computer Assisted Evaluation of Stenosis and Restenosis) system, a computerized automatic analysis system. The 35-mm cine film was projected with a 35AX projector (Tagarno, Denmark), and the cine frame selected for analysis was scanned with a highresolution video camera. The signal produced by the video camera was digitized and displayed on a video monitor. Regions of interest were chosen in the vessel, and a centerline was manually traced with a light pencil. The contours of the vessel were then automatically detected on the basis of the weighted sum of first and second derivative functions applied to the digitized brightness information. The diameter of the coronary catheter was used to convert the imaging data from pixels to millimeters. The mean diameters of proximal and distal reference segments and the minimum diameter of the stenotic segment were measured. We had previously determined the accuracy (defined as the signed difference between the measured and the true value) and the precision (defined as the standard deviation of these differences) of the CAESAR system in a study analyzing cine films of Plexiglas blocks containing precision-drilled models of coronary arteries filled with contrast medium. The accuracy was 0.07 mm, and the precision was 0.14 mm. In a separate study, we analyzed the intraobserver and interobserver variability of the CAESAR system in our institution. Ninety arterial segments from patients undergoing coronary angioplasty were analyzed by two independent observers and reanalyzed at a remote time. The mean intraobserver variation, expressed as the standard error of the estimate (SEE), was 0.10 mm. The interobserver variation (SEE) was 0.11 mm.
The response of the dilated segment was quantified by measuring the minimum diameter of the segment at baseline and after each intervention. The mean diameters of proximal and distal control segments in the dilated vessel, identified by their distance from side branches or from the origin of the vessel, were also determined. For angioplasty procedures on the left coronary artery, the mean diameters of control proximal and distal segments in the nondilated vessel after each intervention were also determined. In the patient who developed complete occlusion and in the three patients who developed subtotal occlusion at the site of the previous angioplasty after infusion of the highest dose of serotonin, the diameter of the control segment distal to the site of angioplasty could not be measured.
Statistical Analysis
All data are expressed as mean±SEM unless otherwise indicated. A one-way ANOVA with a design for repeated measures followed by two-tailed paired Student's t tests with the Bonferroni correction was used for comparison of sequential changes in the absolute values of coronary artery diameters and for comparison of hemodynamic parameters after infusion of graded doses of serotonin. Two-tailed Student's t tests for paired observations were used to test differences in percent reduction in coronary diameter between segments at the maximum infused dose of serotonin. Linear regression analysis was used to determine whether a relation existed between changes in lumen diameter from angioplasty to follow-up and the constrictor response to serotonin at the dilated segments.
Results
Hemodynamic Parameters There were no significant changes in heart rate or in systolic arterial blood pressure associated with intracoronary infusion of saline or of incremental concentrations of serotonin.
Responses of Coronary Vessel Segments
The changes observed in the vessel segments we studied are detailed in Table 2 The constrictor responses that were observed in individual patients at the prestenotic and stenotic sites after infusion of the highest dose of serotonin are illustrated in Fig 2. The degree of constriction at the dilated site was similar whether or not restenosis (defined as the presence of >50% luminal narrowing at the dilated site at follow-up assessed by quantitative coronary angiography) had occurred.
To further investigate whether there was a relation between the degree of constriction to serotonin and the tendency to restenosis in the segments, we determined whether there was a relation between the absolute change in minimal lumen diameter at the dilated site after infusion of the highest dose of serotonin and the absolute change in lumen diameter between angioplasty and follow-up angiography. There was no correlation (r=.23, P=NS) between the two variables (Fig 6) . Symptoms and ECG Changes Eight patients developed chest pain during infusion of the highest concentration of serotonin, with associated ECG changes in seven (ST segment elevation in two, depression in five). In four of these patients, the symptoms were associated with total (in one) or subtotal constrictor responses at the five sites studied. In the center, the responses at the angioplastied site (PTCA) and at proximal (Prox) and distal (Dist) control sites in the dilated vessel are shown. The responses at proximal (Control Prox) and distal (Control Dist) sites in a nondilated vessel are shown at either side. The mean degree of constriction at distal control sites was significantly (P<.01) greater than at the corresponding proximal control sites. The mean degree of constriction at the angioplastied sites was significantly greater (P<.05) than that observed at proximal control sites and equivalent to that observed at distal control sites.
(in three) epicardial occlusion at the site of the previous angioplasty. In the remaining patients, the chest pain was probably related to the diffuse constrictor effect of serotonin on all angiographically visible vessels that we and others have previously documented at similar infused doses.5'9 Clinical Course of Patients Who Developed Vasospasm
In the patient who developed complete occlusion at the site of the previous angioplasty after infusion of serotonin, a noninvasive provocative test for coronary spasm with ergonovine maleate was subsequently performed at the request of the referring physician. No chest pain or ECG changes occurred after intravenous injection of 300 ,tg of ergonovine. This patient, who at the time of angiographic follow-up had developed restenosis and who had effort angina with positive results on exercise testing, declined further intervention. He is mildly symptomatic and on therapy with a calcium antagonist 2 years after his initial angioplasty procedure. One of the three patients who developed subtotal occlusion had mild (55%) restenosis. He was asymptomatic and remains asymptomatic 2.5 years after the initial angioplasty procedure. The other two patients had not developed restenosis. They were asymptomatic at the time of angiography and remain asymptomatic 18 months later. Discussion This study extends the findings of previous reports that have documented an alteration in the response to endothelium-dependent vasoactive agents in atherosclerotic vessels. Our results demonstrate that the intracoronary injection of serotonin is associated with a significantly greater constrictor response at the site of previous arterial injury than at adjacent control sites, and they raise the possibility that this enhanced constrictor response is related to an alteration in the functional responses of endothelium that has regenerated after acute mechanical injury.
Regional Effects of Serotonin on Human Epicardial Vessels In Vivo
We previously studied the response of atherosclerotic coronary vessels to the intracoronary infusion of serotonin and showed that such infusion caused dose-dependent epicardial vasoconstriction and that the constrictor effect, assessed by quantitative coronary angiography, was much more marked in distal than in proximal epicardial vessels.5 Indeed, the most striking angiographic feature after infusion of serotonin was the intense constriction of the tertiary branches of the major vessels and of collateral vessels that were too small to evaluate by quantitative angiographic techniques. These findings suggested that there were regional differences in the response to serotonin in the human coronary circulation. Golino et a19 also demonstrated that serotonin infusion caused dose-dependent epicardial constriction. In addition, they showed that infusion of serotonin at doses that caused only a modest reduction in epicardial crosssectional area was associated with significant reductions in coronary blood flow, suggesting that serotonin has a particularly potent constrictor effect on vessels too small to be seen angiographically. 9 In a subsequent study, we showed that these regional differences in the response to serotonin may be related to differences in the distribution of serotonin receptor subtypes in proximal compared with distal epicardial vessels.10 Ketanserin, a selective antagonist at the S2 receptor subtype, inhibited the constrictor response to serotonin in proximal but not in distal epicardial vessels in patients with atherosclerosis who had chronic stable angina.
We also reported the response of discrete primary coronary stenoses to intracoronary infusion of serotonin.5 In patients with stable effort angina, a similar degree of constriction occurred at stenotic and at prestenotic segments at the maximal infused dose (10-m ol/L) of serotonin. By contrast, we found that in patients with variant angina who had vasospasm superimposed on a single discrete epicardial stenosis, there was a marked hyperreactivity to the constrictor effects of serotonin at the site of the lesion. Total or subtotal epicardial occlusion at the stenotic site occurred at infused doses of serotonin that caused only moderate constriction at the adjacent prestenotic site. 5 The results of the present study once again demonstrate that serotonin is a potent vasoconstrictor of atherosclerotic coronary vessels and that its effects are most marked in the distal epicardial vasculature. They also demonstrate, however, that the intracoronary infusion of serotonin is consistently associated with a greater degree of constriction at the site of a previous angioplasty than at the adjacent proximal nondilated site; indeed, at 4 of the 15 lesions studied, total or subtotal epicardial occlusion occurred at the dilated site.
Potential Mechanisms of Serotonin-Induced Hyperconstriction and Spasm
The mechanisms of this enhanced constrictor response may be multifactorial and cannot be completely of already dysfunctional endothelium is correct, then this implies that the endothelium in atherosclerotic vessels is still capable of producing endothelium-derived relaxing factor(s) and that this stimulated release is reduced in vessel segments that have undergone percutaneous transluminal coronary angioplasty.
Evidence for such a hypothesis derived from intracoronary infusion studies with serotonin can only be circumstantial. First, serotonin, like acetylcholine, has a dual effect on intact coronary vessels: an indirect endothelium-mediated vasodilator effect and a direct vasoconstrictor effect on vascular smooth muscle; therefore, the overall response depends on the sum of these two effects. Furthermore, the overall response is highly dependent on the local concentration of the agonist (serotonin or acetylcholine), since small changes in the infused concentration can convert a dilator response into a constrictor response even in control subjects with angiographically smooth vessels.7 In addition, the constrictor responses of epicardial vessel segments to serotonin and to acetylcholine are dependent on the location of the segment within the coronary tree, the response to both agents being more marked in the distal epicardial vessels.5,7 Thus, a constrictor response to intracoronary infusion of serotonin could be caused by an impairment of the relaxant response mediated by the endothelium to an enhanced production of endothelium-derived constricting factors, to an enhanced reactivity of vascular smooth muscle, or to a combination of these mechanisms.
Studies on human epicardial vessels in vitro and in vivo that used substance P have provided evidence that atherosclerotic vessels retain the ability to produce endothelium-derived relaxing factor(s).13'14 Atherosclerotic human coronary vessels that respond to intracoronary infusion of acetylcholine with constriction retain a dilator response to the intracoronary infusion of substance pl15 The dilator effect of substance P on vessel segments with intact endothelium is caused solely by a stimulated release of endothelium-derived relaxing factor(s), since it is abolished by mechanical removal of the endothelium. 16 These observations suggest that atherosclerotic human coronary vessels retain the ability to produce endothelium-derived relaxing factor(s). It is therefore possible that the hyperreactive response to serotonin that we have documented at the site of previous angioplasty compared with the response at the adjacent nondilated proximal control site reflects a further functional impairment of the endothelium at such sites related to the previous injury.
It is also possible that the hyperconstriction at the site of previous angioplasty reflects an studied the effects of methylergonovine in 14 consecu-tive patients 6 weeks to 3 months after successful single-vessel angioplasty. Intravenous infusion of ergonovine provoked focal spasm at the previously dilated site in 5 patients: the mean reduction in lumen diameter at the dilated site was 51% in the patients who developed spasm; by contrast, the reduction in luminal diameter at the adjacent proximal control site was consistently <20%. By contrast, el-Tamimi et al19 recently demonstrated that the intracoronary injection of ergonovine 1 week after angioplasty in 12 consecutive patients who had undergone single-vessel coronary angioplasty caused a degree of constriction at the angioplasty site similar to that at control nondilated sites. The explanation for these apparently contradictory observations may be related to the time period that elapsed between the angioplasty procedure and the performance of the provocative tests. In the dog, it has been demonstrated that large coronary vasomotion in response to ergonovine does not change at all from 1 to 10 days after endothelial denudation,20 whereas at 1 month after denudation, there is a marked hyperreactivity to the constrictor effects of ergonovine at the dilated site. 21 Another recent study demonstrated that the constrictor response to intracoronary infusion of acetylcholine was similar at dilated sites and at nondilated proximal control sites 1 week after coronary angioplasty in humans. 22 However, the degree of constriction of the control segments distal to the angioplasty site was significantly greater than that observed in the distal segments of a control nondilated artery. In the present study, the constrictor response that was observed in some patients at control segments distal to the dilated site was greater than that observed at the corresponding control sites in the nondilated artery. Although the mean degree of constriction response of the control segments distal to the angioplasty site was not significantly different from that observed in the distal segments of a control nondilated artery, it was of course not possible to assess the behavior of the distal segment in the dilated vessel in the subgroup of patients who developed severe constriction at the angioplasty site. Further studies that use lower doses of serotonin in conjunction with Doppler measurements of coronary flow may help to clarify the effect of angioplasty on the response of small coronary vessels to serotonin.
Potential Limitations
There are methodological difficulties in comparing the responses of coronary segments that have differing absolute diameters. The use of percent change relative to baseline for comparisons between segments magnifies changes that occur in smaller coronary segments. Our previous work suggests that the constrictor response to serotonin is greater in distal than in proximal coronary segments, perhaps related to regional differences in the distribution of serotonin receptor subtypes. Thus, the demonstration that previously angioplastied sites constrict much more than adjacent proximal control segments and to the same extent as distal segments is consistent with a real difference in the behavior of such segments in response to serotonin. Furthermore, total or subtotal epicardial occlusion occurred after serotonin infusion at 4 of the 15 angioplasty sites. We have never observed such a response in proximal or distal sites, in stenotic or in nonstenotic vessels, in patients who had stable ischemic heart disease. Finally, the similar degree of constriction to serotonin at angioplasty sites that had <50% or >50% stenosis at control angiography and the lack of correlation between the constrictor response to serotonin and the loss in lumen diameter between angioplasty and follow-up suggest that the observed responses cannot be explained by geometric or lesion-related factors alone.
Conclusions
The results of this study demonstrate that after the acute mechanical injury associated with coronary angioplasty, there is a more marked constrictor response to serotonin at the site of such injury than at nondilated sites. This could be a result of an alteration in the functional properties of endothelium that has regenerated after injury, of a hyperreactivity of vascular smooth muscle cells at the site of the previous angioplasty, of a combination of these factors, or of other as yet unelucidated factors. The demonstration that an enhanced constrictor response to an endothelium-dependent vasoactive agent occurs after angioplasty raises the possibility that altered vasomotor reactivity related to the angioplasty procedure itself may be one of the factors that facilitates the process of restenosis. This possibility is consistent with the results of clinical studies that have demonstrated that the presence of coronary vasospasm induced by ergonovine 6 months after successful coronary angioplasty was frequently accompanied by restenosis,' and that the presence of an abnormal vasomotor response before angioplasty is strongly predictive of subsequent restenosis.2
